The Veriblog

Blogger Spotlight: ONC’s Response to ASCO 2017

Even though ASCO 2017 wrapped up over a month ago, we are still pretty curious and interested in what’s to come from the oncology community. We’re especially excited to hear what real attendees have to say about their experiences.

 

Our curiosity sparked us to reach out to one of our Oncologists who went to ASCO 2017, and find out what he really thought about the plenary session topic, which focused on a symptom tracking tool to help foster better communication and outcomes (link here).

 

With a topic so close to our hearts at Verilogue,  we were extra intrigued to hear a physician’s reaction!

Read more…

Trends in Oncology: Metaphor Basics

The treatment discussion as a whole has been impacted by the launch of new classes of treatment and new products over the past year. One third (10/30) of newly approved molecules in the European Union in 2016 were drugs for use in oncology.

As we continue our look at trends across Verilogue’s conversation database, one common device physicians and patients often can use to discuss treatment options is a metaphor.

Read more…

ONCs’ Top Tips for Attending ASCO 2017

Every year marketers, HCPs, and researchers gather at ASCO (American Society of Clinical Oncology) to learn about the newest breakthroughs and developments in the war on cancer. With a large variety of progress across all cancer types, this conference is a great opportunity for individuals to stay on top of industry news.

 

With a lot of advancement and information to pack into 4 days, there’s a unique planning challenge for individuals attending to make the most of their time. Attendees need to set their itineraries, but also need to make sure the content they are seeking is most relevant to their professional goals. That’s why we polled our doctors and ASCO veterans to see what mattered most to them in preparation for this year’s conference.

Read more…

%d bloggers like this: